News
-
MultiSim’s collaboration with NC3Rs to reduce animal testing
Researchers on the MultiSim project are trying to find ways to reduce animal testing in preclinical trials by using computer models and medical imaging.
-Read more-
-
Certara, the leading provider of in silico drug development technologies, to be bought by EQT
On Tuesday 11 July 2017 Arsenal Capital Partners announced to be in the process to sell its portfolio company Certara to the private equity firm EQT
-Read more-
-
Great achievements for the EU funded CHIC project
In a recent press release the EC officially speaks about the “great achievements” of the EU-US integrating research project on in silico oncology: CHIC
-Read more-
-
EMA- Revised guideline on first-in-human clinical trials
On 26 July, the European Medicines Agency (EMA) presented a first revision of the guideline on first-in-human clinical trials, which outlines strategies to identify and mitigate risks for trial participants.
-Read more-
-
IMI launches €130 million calls for proposals
On 19 July, the Innovative Medicines Initiative (IMI) launched two new Calls for proposals (Call 11 and Call 12) with topics regarding Alzheimer’s disease, big data, vaccines, autoimmune disease, the blood-brain barrier, drug development, and the exploitation of IMI project results with a total budget of over € 130 million.
-Read more-
-
EPSCO informal meeting
On 20 July an informal meeting of EPSCO (Employment, Social Policy, Health and Consumer Affairs Council configuration) in Tallinn, the EU ministers for health discussed the future of digital solutions in health.
-Read more-
